2023
DOI: 10.1016/j.cej.2022.139021
|View full text |Cite
|
Sign up to set email alerts
|

Multimodal capture − antibody-independent lateral flow immunoassay based on AuNF − PMBA for point-of-care diagnosis of bacterial urinary tract infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(8 citation statements)
references
References 49 publications
0
8
0
Order By: Relevance
“…Additionally, the pH and ionic strength of the matrix solution affect the binding process of the antibodies and nanomaterials. In contrast to the traditional LFSB model, some researchers have investigated a label-free LFSB based on the nanomaterial-bacteria-antibody sandwich model. These special nanomaterials can not only act as recognition agents to capture target pathogenic bacteria but also provide sensing signals, thus allowing the direct detection for pathogenic bacteria without nanomaterial-labeled antibodies. In addition, this label-free mode eliminates the screening process of antibody pairs for pathogenic bacteria, which greatly saves time and reduces costs.…”
Section: Lfsbs For Direct Detection Of Foodborne Pathogenic Bacteriamentioning
confidence: 99%
“…Additionally, the pH and ionic strength of the matrix solution affect the binding process of the antibodies and nanomaterials. In contrast to the traditional LFSB model, some researchers have investigated a label-free LFSB based on the nanomaterial-bacteria-antibody sandwich model. These special nanomaterials can not only act as recognition agents to capture target pathogenic bacteria but also provide sensing signals, thus allowing the direct detection for pathogenic bacteria without nanomaterial-labeled antibodies. In addition, this label-free mode eliminates the screening process of antibody pairs for pathogenic bacteria, which greatly saves time and reduces costs.…”
Section: Lfsbs For Direct Detection Of Foodborne Pathogenic Bacteriamentioning
confidence: 99%
“…Moreover, the ability to cross-validate between different modes further bolsters the reliability of the results. 8,9 Consequently, the development of novel LFIA sensors is imperative.…”
Section: Introductionmentioning
confidence: 99%
“…Fortunately, the emergence of novel LFIAs featuring two or more output signals, namely dual-mode LFIAs (dLFIAs) or multimode LFIAs (mLFIAs) has made it possible to break the aforementioned bottlenecks. , These novel LFIAs preserve the simplicity of colorimetric mode while incorporating quantitative modes of varying sensitivities, which can meet the detection requirements of diverse scenarios and greatly increase the sensitivity and accuracy of detection. Moreover, the ability to cross-validate between different modes further bolsters the reliability of the results. , Consequently, the development of novel LFIA sensors is imperative.…”
Section: Introductionmentioning
confidence: 99%
“…Lateral flow immunoassay (LFIA) is a widely utilized tool for point-of-care (POC) detection. Multimodal LFIA technology has developed rapidly and has been successfully applied to food testing, , in vitro diagnostics, , and environmental monitoring recent years. , Multisignal LFIA sensors are constructed by integrating antibodies (monoclonal, polyclonal, and nanobody) and nanomaterials (noble metal nanomaterials, carbon nanomaterials, quantum dots and nanoenzymes, etc. ), which can provide multiple signal outputs, mainly including colorimetric signals, fluorescent signals, Raman signals, electrochemical signals and thermal signals .…”
Section: Introductionmentioning
confidence: 99%